FAT1 and head and neck squamous cell carcinoma: In addition, there were no significant differences in five‐year OS and RFS rates between FAT1 wild‐type and mutated subgroups in the TCGA HNSCC cohort (P = 0.2 and 0.2, respectively; Fig. S2E,F).